Literature DB >> 27712781

Carbamylated Low-Density Lipoprotein and Thrombotic Risk in Chronic Kidney Disease.

W H Wilson Tang1, Stanley L Hazen2.   

Abstract

Entities:  

Keywords:  carbamylation; end-stage renal disease; low-density lipoprotein; myeloperoxidase; uremia

Mesh：

Substances：

Year:  2016        PMID： 27712781      PMCID： PMC5659112          DOI： 10.1016/j.jacc.2016.08.006

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  11 in total

1.  Carbamylated low-density lipoprotein induces endothelial dysfunction.

Authors:  Thimoteus Speer; Frederick O Owala; Erik W Holy; Stephen Zewinger; Felix L Frenzel; Barbara E Stähli; Marjan Razavi; Sarah Triem; Hrvoje Cvija; Lucia Rohrer; Sarah Seiler; Gunnar H Heine; Vera Jankowski; Joachim Jankowski; Giovanni G Camici; Alexander Akhmedov; Danilo Fliser; Thomas F Lüscher; Felix C Tanner
Journal:  Eur Heart J       Date:  2014-03-21       Impact factor: 29.983

2.  Protein carbamylation predicts mortality in ESRD.

Authors:  Robert A Koeth; Kamyar Kalantar-Zadeh; Zeneng Wang; Xiaoming Fu; W H Wilson Tang; Stanley L Hazen
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

3.  Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes.

Authors:  W H Wilson Tang; Kevin Shrestha; Zeneng Wang; Allen G Borowski; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  J Card Fail       Date:  2013-03-19       Impact factor: 5.712

4.  Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease.

Authors:  Ercan Ok; Alexei G Basnakian; Eugene O Apostolov; Yousri M Barri; Sudhir V Shah
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

5.  The interaction of carbamylated low-density lipoprotein with cultured cells. Studies with human fibroblasts, rat peritoneal macrophages and human monocyte-derived macrophages.

Authors:  B Gonen; T Cole; K S Hahm
Journal:  Biochim Biophys Acta       Date:  1983-11-29

6.  Chronic uremia stimulates LDL carbamylation and atherosclerosis.

Authors:  Eugene O Apostolov; Debarti Ray; Alena V Savenka; Sudhir V Shah; Alexei G Basnakian
Journal:  J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 10.121

7.  Protein carbamylation links inflammation, smoking, uremia and atherogenesis.

Authors:  Zeneng Wang; Stephen J Nicholls; E Rene Rodriguez; Outi Kummu; Sohvi Hörkkö; John Barnard; Wanda F Reynolds; Eric J Topol; Joseph A DiDonato; Stanley L Hazen
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

8.  Abnormal cell-interactive properties of low-density lipoproteins isolated from patients with chronic renal failure.

Authors:  B Gonen; A P Goldberg; H R Harter; G Schonfeld
Journal:  Metabolism       Date:  1985-01       Impact factor: 8.694

9.  Carbamylated Low-Density Lipoproteins Induce a Prothrombotic State Via LOX-1: Impact on Arterial Thrombus Formation In Vivo.

Authors:  Erik W Holy; Alexander Akhmedov; Thimoteus Speer; Giovanni G Camici; Stephen Zewinger; Nicole Bonetti; Jürg H Beer; Thomas F Lüscher; Felix C Tanner
Journal:  J Am Coll Cardiol       Date:  2016-10-11       Impact factor: 24.094

Review 10.  Protein carbamylation and cardiovascular disease.

Authors:  Frederik H Verbrugge; W H Wilson Tang; Stanley L Hazen
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612
View more
  2 in total

1.  Association of carbamylated high-density lipoprotein with coronary artery disease in type 2 diabetes mellitus: carbamylated high-density lipoprotein of patients promotes monocyte adhesion.

Authors:  Zhongli Chen; Song Ding; Yan Ping Wang; Liang Chen; Jing Yan Mao; Ying Yang; Jia Teng Sun; Ke Yang
Journal:  J Transl Med       Date:  2020-12-03       Impact factor: 5.531

Review 2.  Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity-Receptors and Signalling Mechanisms.

Authors:  Martin Berger; Khalid M Naseem
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.